drugset / Trial / NCT07767175
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to find out if NNC0721-8060 is safe and how it works in people living with overweight or obesity.
Timeline
- Start
- 2026-08-12
- Primary completion
- 2027-09-23
- Completion
- 2027-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NNC0721-8060 | Unknown | — | Subcutaneous |
| Comparator | Semaglutide | Peptide | — | Subcutaneous |